>_ QFI Terminal
TerminalStocks › DHR

Danaher Corporation (DHR) Stock

Healthcare · Medical - Diagnostics & Research · US
$211.77 -0.34%
Last updated Sep 20, 2026 13:47 UTC

DHR Key Statistics

Market Cap$148.87B
P/E (TTM)37.61
P/S (TTM)5.93
P/B (TTM)2.84
Revenue (TTM)$25.11B
EPS (TTM)$5.63
Dividend Yield0.54%
ROE (TTM)7.66%
Net Margin15.95%
Gross Margin58.51%
52W High$242.80
52W Low$160.93
Analyst ViewBuy
Price Target$223.77
Employees59,000
Volume8,781,904

About Danaher Corporation

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.

CEO: Rainer Blair. Company website

DHR — Frequently Asked Questions

What is the DHR stock price today?

Danaher Corporation (DHR) trades at $211.77, down 0.34% on the day, as of Sep 20, 2026 13:47 UTC.

What is Danaher Corporation's market cap?

Danaher Corporation has a market capitalisation of $148.87B, calculated from the live DHR share price and shares outstanding.

What is the P/E ratio of DHR?

DHR trades at a trailing P/E of 37.61, from earnings per share of $5.63 over the last twelve months.

How much revenue does Danaher Corporation make?

Danaher Corporation generated revenue of $25.11B over the trailing twelve months, which puts the stock at 5.93 times sales.

Does DHR pay a dividend?

Yes. Danaher Corporation pays a dividend yielding 0.54% on the current share price.

What is the 52-week range for DHR?

DHR has traded between $160.93 and $242.80 over the past 52 weeks, and the last price is 12.8% below that high.

Is Danaher Corporation profitable?

Yes. Danaher Corporation keeps 15.95% of revenue as net income over the trailing twelve months.

What is the analyst price target for DHR?

Wall Street analysts rate DHR Buy, with an average price target of $223.77, 5.7% above the current price.

What sector is Danaher Corporation in?

Danaher Corporation is classified under the Healthcare sector and the Medical - Diagnostics & Research industry, and is domiciled in US.

Who is the CEO of Danaher Corporation?

Rainer Blair is the chief executive of Danaher Corporation, which employs 59,000 people.

Where can I track DHR in real time?

QFI Terminal shows DHR with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See DHR live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open DHR in Terminal See plans

Medical - Diagnostics & Research stocks

TMO Thermo Fisher Scientific Inc. IQV IQVIA Holdings Inc. LH Labcorp Holdings Inc. DGX Quest Diagnostics Incorporated ICLR ICON Public Limited Company A Agilent Technologies, Inc. WAT Waters Corporation IDXX IDEXX Laboratories, Inc.

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corp. MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CI Cigna Corporation CAH Cardinal Health, Inc. ELV Elevance Health Inc.